Latest News and Press Releases

A heavily politicized process suppressed the use of safe, affordable, repurposed drugs such as hydroxychoroquine for early treatment of COVID.

Evidence for benefit of hydroxychloroquine and other "off-label" drugs for COVID is hidden in plain sight, says infectious disease specialist.

TUCSON, Ariz., Sept. 30, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) filed its motion and amicus brief Thursday evening with the federal district court in...

TUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- While Secretary of Defense Lloyd Austin has stated that mandatory COVID-19 vaccination is needed to protect the health and readiness of the armed...

SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Ebvia, a biotechnology developing simple-to-use therapeutics for the treatment and prevention of COVID-19, today announces the publication entitled...

TUCSON, Ariz., Jan. 13, 2022 (GLOBE NEWSWIRE) -- In response to calls for doubling down on costly failed public health strategies, the Arizona State Chapter of the Association of American Physicians...

TUCSON, Ariz., Oct. 13, 2021 (GLOBE NEWSWIRE) -- In response to public interest in the use of a common disinfectant, povidone-iodine (PVP-I or Betadine™), to prevent or ameliorate COVID-19, popular...

TUCSON, Ariz., Aug. 23, 2021 (GLOBE NEWSWIRE) -- An updated version of the popular booklet by the Association of American Physicians and Surgeons (AAPS), A Guide to Home-Based COVID Treatment, is...

TUCSON, Ariz. , Aug. 20, 2021 (GLOBE NEWSWIRE) -- In response to a strongly worded call to delicense physicians who “generate and spread COVID-19 vaccine misinformation or disinformation,” issued by...

TUCSON, Ariz., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Upon learning of Gov. Greg Abbott’s COVID-19 diagnosis, the Association of American Physicians and Surgeons (AAPS) and its Texas chapter sent the...